14 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/14/3060770/0/en/Soleno-Therapeutics-Announces-VYKAT-TM-XR-Launch.html
28 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/pantherx-rare-selected-by-soleno-therapeutics-for-the-distribution-of-vykat-xr-302414400.html
27 Mar 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-greenlights-first-ever-treatment-rare-metabolic-disorder-2025-03-26/
26 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/26/2987503/0/en/Soleno-Therapeutics-Announces-FDA-Extension-of-Review-Period-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome.html
14 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/14/2981587/0/en/Soleno-Therapeutics-Announces-Oral-Presentations-featuring-Diazoxide-Choline-Extended-Release-DCCR-Tablets-in-Prader-Willi-Syndrome-at-ESPE-2024.html
08 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/10/08/2959708/0/en/Soleno-Therapeutics-Announces-Regulatory-Update-on-DCCR-diazoxide-choline-Extended-Release-Tablets-to-Treat-Prader-Willi-Syndrome.html